Cargando…

A new tool for tuberculosis vaccine screening: Ex vivo Mycobacterial Growth Inhibition Assay indicates BCG-mediated protection in a murine model of tuberculosis

BACKGROUND: In the absence of a validated animal model and/or an immune correlate which predict vaccine-mediated protection, large-scale clinical trials are currently the only option to prove efficacy of new tuberculosis candidate vaccines. Tools to facilitate testing of new tuberculosis (TB) vaccin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zelmer, Andrea, Tanner, Rachel, Stylianou, Elena, Damelang, Timon, Morris, Sheldon, Izzo, Angelo, Williams, Ann, Sharpe, Sally, Pepponi, Ilaria, Walker, Barry, Hokey, David A., McShane, Helen, Brennan, Michael, Fletcher, Helen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4983071/ https://www.ncbi.nlm.nih.gov/pubmed/27519524 http://dx.doi.org/10.1186/s12879-016-1751-4

Ejemplares similares

The Cross-Species Mycobacterial Growth Inhibition Assay (MGIA) Project, 2010–2014
por: Brennan, Michael J., et al.
Publicado: (2017)

A mycobacterial growth inhibition assay (MGIA) for bovine TB vaccine development
por: Pepponi, Ilaria, et al.
Publicado: (2017)

Historical BCG vaccination combined with drug treatment enhances inhibition of mycobacterial growth ex vivo in human peripheral blood cells
por: Prabowo, Satria A., et al.
Publicado: (2019)

Non-tuberculous mycobacteria have diverse effects on BCG efficacy against Mycobacterium tuberculosis()
por: Poyntz, Hazel C., et al.
Publicado: (2014)

Immunological correlates of mycobacterial growth inhibition describe a spectrum of tuberculosis infection
por: O’Shea, Matthew K., et al.
Publicado: (2018)

Evaluation of a Human BCG Challenge Model to Assess Antimycobacterial Immunity Induced by BCG and a Candidate Tuberculosis Vaccine, MVA85A, Alone and in Combination
por: Harris, Stephanie A., et al.
Publicado: (2014)

Gene Expression and Cytokine Profile Correlate With Mycobacterial Growth in a Human BCG Challenge Model
por: Matsumiya, Magali, et al.
Publicado: (2015)

Inflammation and immune activation are associated with risk of Mycobacterium tuberculosis infection in BCG-vaccinated infants
por: Satti, Iman, et al.
Publicado: (2022)

Adaption of the ex vivo mycobacterial growth inhibition assay for use with murine lung cells
por: Painter, Hannah, et al.
Publicado: (2020)

Development of a non-human primate BCG infection model for the evaluation of candidate tuberculosis vaccines
por: Harris, Stephanie A., et al.
Publicado: (2018)

The influence of haemoglobin and iron on in vitro mycobacterial growth inhibition assays
por: Tanner, Rachel, et al.
Publicado: (2017)

Factors influencing the higher incidence of tuberculosis among migrants and ethnic minorities in the UK
por: Hayward, Sally, et al.
Publicado: (2018)

Author Correction: The influence of haemoglobin and iron on in vitro mycobacterial growth inhibition assays
por: Tanner, Rachel, et al.
Publicado: (2019)

The Humoral Immune Response to BCG Vaccination
por: Tanner, Rachel, et al.
Publicado: (2019)

A New Vaccine for Tuberculosis: The Challenges of Development and Deployment
por: Fletcher, Helen A., et al.
Publicado: (2009)

Development of a BCG challenge model for the testing of vaccine candidates against tuberculosis in cattle
por: Villarreal-Ramos, Bernardo, et al.
Publicado: (2014)

Cholera Toxin Enhances Vaccine-Induced Protection against Mycobacterium Tuberculosis Challenge in Mice
por: Griffiths, Kristin L., et al.
Publicado: (2013)

High monocyte to lymphocyte ratio is associated with impaired protection after subcutaneous administration of BCG in a mouse model of tuberculosis
por: Zelmer, Andrea, et al.
Publicado: (2018)

Mucosal delivery of tuberculosis vaccines: a review of current approaches and challenges
por: Stylianou, Elena, et al.
Publicado: (2019)

Editorial Commentary: Understanding BCG Is the Key to Improving It
por: McShane, Helen
Publicado: (2014)

Human Hookworm Infection Enhances Mycobacterial Growth Inhibition and Associates With Reduced Risk of Tuberculosis Infection
por: O'Shea, Matthew K., et al.
Publicado: (2018)

Tuberculosis vaccines: beyond bacille Calmette–Guérin
por: McShane, Helen
Publicado: (2011)

MYCOBACTERIAL ABSCESSES AFTER BCG VACCINATION
por: Brennan, R, et al.
Publicado: (2019)

RUTI Vaccination Enhances Inhibition of Mycobacterial Growth ex vivo and Induces a Shift of Monocyte Phenotype in Mice
por: Prabowo, Satria A., et al.
Publicado: (2019)

Local Pulmonary Immunological Biomarkers in Tuberculosis
por: Morrison, Hazel, et al.
Publicado: (2021)

Regulation of mycobacterial infection by macrophage Gch1 and tetrahydrobiopterin
por: McNeill, Eileen, et al.
Publicado: (2018)

High-dose Mycobacterium tuberculosis aerosol challenge cannot overcome BCG-induced protection in Chinese origin cynomolgus macaques; implications of natural resistance for vaccine evaluation
por: Sibley, Laura, et al.
Publicado: (2021)

Controlled Human Infection Models: Is it Really Feasible to Give People Tuberculosis?
por: McShane, Helen
Publicado: (2020)

Improving Tuberculosis Vaccine Trial Efficiency: A Tough Nut to Crack
por: McShane, Helen
Publicado: (2023)

A systematic review of the impact of psychosocial factors on immunity: Implications for enhancing BCG response against tuberculosis
por: Hayward, Sally E., et al.
Publicado: (2019)

Distinct Transcriptional and Anti-Mycobacterial Profiles of Peripheral Blood Monocytes Dependent on the Ratio of Monocytes: Lymphocytes
por: Naranbhai, Vivek, et al.
Publicado: (2015)

Safety and Immunogenicity of Boosting BCG Vaccinated Subjects with BCG: Comparison with Boosting with a New TB Vaccine, MVA85A
por: Whelan, Kathryn T., et al.
Publicado: (2009)

Why don’t we have an effective tuberculosis vaccine yet?
por: Davenne, Tamara, et al.
Publicado: (2016)

The Tuberculin Skin Test (TST) Is Affected by Recent BCG Vaccination but Not by Exposure to Non-Tuberculosis Mycobacteria (NTM) during Early Life
por: Burl, Sarah, et al.
Publicado: (2010)

Correction: Safety and Immunogenicity of Boosting BCG Vaccinated Subjects with BCG: Comparison with Boosting with a New TB Vaccine, MVA85A
por: Whelan, Kathryn T., et al.
Publicado: (2011)

Using Data from Macaques To Predict Gamma Interferon Responses after Mycobacterium bovis BCG Vaccination in Humans: a Proof-of-Concept Study of Immunostimulation/Immunodynamic Modeling Methods
por: Rhodes, Sophie J., et al.
Publicado: (2017)

Tools for Assessing the Protective Efficacy of TB Vaccines in Humans: in vitro Mycobacterial Growth Inhibition Predicts Outcome of in vivo Mycobacterial Infection
por: Tanner, Rachel, et al.
Publicado: (2020)

Transcriptional profiling of mycobacterial antigen-induced responses in infants vaccinated with BCG at birth
por: Fletcher, Helen A, et al.
Publicado: (2009)

Antibodies and tuberculosis
por: Jacobs, Ashley J., et al.
Publicado: (2016)

The next 10 years for tuberculosis vaccines: do we have the right plans in place?
por: Meyer, Joel, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_35bab82704bj723310ite0h8lq